A Case of Guillain-Barré Syndrome Complicated by Refractory Cytomegalovirus Disease

Affiliations

¹ Department of Organ Transplantation, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.

Hengyu Zhao et al. J Med Virol. 2025 Oct.

. 2025 Oct;97(10):e70619.

doi: 10.1002/jmv.70619.

¹ Department of Organ Transplantation, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.

No abstract available

References

1. N. Shahrizaila, H. C. Lehmann, and S. Kuwabara, “Guillain‐Barré Syndrome,” Lancet 397, no. 10280 (2021): 1214–1228, https://doi.org/10.1016/S0140-6736(21)00517-1.
1. D. Orlikowski, R. Porcher, V. Sivadon‐Tardy, et al., “Guillain‐Barre Syndrome Following Primary Cytomegalovirus Infection: A Prospective Cohort Study,” Clinical Infectious Diseases 52, no. 7 (2011): 837–844, https://doi.org/10.1093/cid/cir074.
1. C. Steininger, T. Popow‐Kraupp, A. Seiser, N. Gueler, G. Stanek, and E. Puchhammer, “Presence of Cytomegalovirus in Cerebrospinal Fluid of Patients With Guillain‐Barré Syndrome,” Journal of Infectious Diseases 189, no. 6 (2004): 984–989, https://doi.org/10.1086/382192.
1. C. S. Walti, N. Khanna, R. K. Avery, and I. Helanterä, “New Treatment Options for Refractory/Resistant CMV Infection,” Transplant International 36 (2023): 11785, https://doi.org/10.3389/ti.2023.11785.
1. L. R. Baden, S. Swaminathan, M. Angarone, et al., “Prevention and Treatment of Cancer‐Related Infections, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology,” Journal of the National Comprehensive Cancer Network 14, no. 7 (2016): 882–913, https://doi.org/10.6004/jnccn.2016.0093.